Biocon Share Price Today

Biocon shares worth ₹39.04 crore change hands in large trade

A large-trade signal flagged approximately 1,057,554 Biocon shares on NSE. Shares changed hands at ₹369.20, for a combined value of ₹39.04 crore. This is a real-time signal and not a confirmed exchange-reported event. Buyer, seller, and broker identities remain unknown until exchange disclosure after market close.

Biocon Malaysia unit gets MHRA approval for Semglee insulin

Biocon's Malaysian fill-finish unit for Semglee® insulin received MHRA approval on September 25, 2026. The clearance follows an earlier EMA approval for the same line secured in July 2026. Dual regulatory nods validate operational readiness for commercial production in Europe and the UK.

Biocon's Pebrilzo becomes first biosimilar to get EMA CHMP nod via tailored approach

Biocon's Pebrilzo receives EMA CHMP positive opinion for marketing authorisation. It is the first monoclonal antibody biosimilar approved under the tailored clinical development approach. Product treats HER2-positive breast cancer in neoadjuvant, adjuvant, and metastatic settings. European Commission to conduct final review before EU marketing authorisation is granted.

Biocon declares ₹0.50 per share final dividend for FY26

Biocon declared a final dividend of ₹0.50 per equity share for FY26. Shareholders on record as of July 3, 2026, are eligible for the payout. The dividend was approved at the AGM held on August 6, 2026. Payouts have been remitted electronically to registered accounts.

Biocon schedules investor roadshow in Mumbai on September 11

Biocon Limited hosts an investor roadshow on September 11, 2026. Management meets analysts and institutional investors in Mumbai. Interactions include both one-on-one and group formats. No UPSI will be disclosed during the meetings. Schedule is subject to change based on exigencies.

Biocon to host virtual analyst meet on September 4, 2026

Biocon to host virtual analyst meet on September 4, 2026. Session part of Nomura Asian Credit Corporate Day 2026. No UPSI to be disclosed during interaction. Intimation issued under SEBI Regulation 30(6).